1. GSTP1 as a potential predictive factor for adverse events associated with platinum‑based antitumor agent‑induced peripheral neuropathy
   Sou Katayanagi et al, 2019, Oncology Letters CrossRef
2. Predictive biomarkers for targeted and cytotoxic agents in gastric cancer for personalized medicine
   Shalong Wang et al, 2016, BioScience Trends CrossRef
3. Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics?
   Goretti Duran et al, 2020, Journal of Chemotherapy CrossRef
4. Effects of gene polymorphisms on the risk of severe hyponatremia during DCF chemotherapy for patients with esophageal squamous cell carcinoma
   Yasuhiro Arakawa et al, 2018, Oncology Letters CrossRef
5. A Genotyping/Phenotyping Approach with Careful Clinical Monitoring to Manage the Fluoropyrimidines-Based Therapy: Clinical Cases and Systematic Review of the Literature
   Valeria Conti et al, 2020, Journal of Personalized Medicine CrossRef
6. Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based Therapy
   Corine de Jong et al, 2023, Genes CrossRef
7. Association between Polymorphisms in XRCC1 Gene and Treatment Outcomes of Patients with Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
   Zhuo Cao et al, 2014, PLoS ONE CrossRef
8. Predictive value of GSTP1 Ile105Val polymorphism in clinical outcomes of chemotherapy in gastric and colorectal cancers: a systematic review and meta-analysis
   Xiaobing Shen et al, 2016, Cancer Chemotherapy and Pharmacology CrossRef
9. Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
   Roser Velasco et al, 2021, Journal of Personalized Medicine CrossRef
10. Informative gene network for chemotherapy-induced peripheral neuropathy
    Cielito C. Reyes-Gibby et al, 2015, BioData Mining CrossRef
11. XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis
    Guobing Wang et al, 2024, Aging CrossRef
12. Association of XRCC1 gene polymorphisms with susceptibility to gastric cancer in Chinese Han population
    Hua Meng et al, 2014, Journal of Pharmacy and Pharmacology CrossRef
13. Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
    Eva Martinez-Balibrea et al, 2015, Molecular Cancer Therapeutics CrossRef
14. Autophagic death induced by thermo-chemotherapy in gastric cancer cells results from the reactive oxygen species pathway
    Yinbing Wu et al, 2016, Molecular Medicine Reports CrossRef
15. Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
    Karolina Tecza et al, 2018, Oncotarget CrossRef
16. Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy
    Zheng-mao Lu et al, 2014, Tumor Biology CrossRef
17. Cost-minimization analysis of GSTP1c.313A>G genotyping for the prevention of cisplatin-induced nausea and vomiting: A Bayesian inference approach
    Ligia Traldi Macedo et al, 2019, PLOS ONE CrossRef
18. XRCC1 and XPD genetic polymorphisms and clinical outcomes of gastric cancer patients treated with oxaliplatin-based chemotherapy: a meta-analysis
    Xin Zhang et al, 2014, Tumor Biology CrossRef
19. A DPYD Variant (Y186C) Specific to Individuals of African Descent in a Patient With Life-Threatening 5-FU Toxic Effects: Potential for an Individualized Medicine Approach
    Muhammad Wasif Saif et al, 2014, Mayo Clinic Proceedings CrossRef
20. Genetic Polymorphisms of Glutathione S-Transferase P1 (GSTP1) and the Incidence of Anti-Tuberculosis Drug-Induced Hepatotoxicity
    Shouquan Wu et al, 2016, PLOS ONE CrossRef
21. Expression deregulation of DNA repair pathway genes in gastric cancer
    Shahzad Yousaf et al, 2019, Cancer Genetics CrossRef
22. The molecular genetics of chemotherapy–induced peripheral neuropathy: A systematic review and meta-analysis
    J. Cliff et al, 2017, Critical Reviews in Oncology/Hematology CrossRef